Overview

Observational Study on Efficacy and Safety of Liraglutide in Subjects With Type 2 Diabetes

Status:
Completed
Trial end date:
2013-11-01
Target enrollment:
Participant gender:
Summary
This observational study is conducted in Europe. The aim of this non-interventional (observational) study is to evaluate the efficacy of liraglutide (Victoza®) and to assess the conditions of use of Victoza® in daily medical practice in France.
Details
Lead Sponsor:
Novo Nordisk A/S
Treatments:
Liraglutide